Trial wisely
An elegantly-architected platform. Precision-built products. Rigorously-defined processes. And exceptionally-prepared people. It’s how, at Suvoda, we empower sponsors, sites, and patients to more artfully take command over infinite, interdependent, and ever-changing variables. Across the full lifespan of your study, you’ll find every minute of every day is calmer and more controlled.
The mission-critical, time-sensitive, and deeply-human interactions that move life-changing studies forward
At Suvoda, we find that the most difficult things are often the most important—and rewarding—things to do.
We founded our business by taking on randomization and drug supply complexities in oncology, CNS, and rare disease studies. We delivered one of the industry’s premiere IRT solutions—a unique combination of software, standards, and support. With Suvoda IRT, sponsor teams and site professionals found it easy to get and give the right drug dose right where and when a patient is ready for a treatment.
As we’ve expanded our portfolio, we’ve continued to apply our proven Suvoda approach to similar mission-critical, time-sensitive, and deeply-human moments in clinical trials—the urgent moments, like informed consent, visit scheduling, outcomes reporting, and patient payment, that if missed, can both stall science and upend lives.
Today, the Suvoda Platform and our IRT, eConsent, and eCOA product suite embraces the inherent complexity in life-changing trials, harnessing it to transform the journey for everyone involved. The result? Sponsor teams, site professionals, and patient participants alike can make more informed, more nuanced decisions. They can smoothly and seamlessly take urgent action, no matter where they are, right when it’s required. In short, they can Trial wisely—and ultimately, better help advance human health.
A team that stays with you for the lifespan of your trial
A team that stays with you for the lifespan of your trial
Delivering to the highest of clinical trial quality levels
Delivering to the highest of clinical trial quality levels